HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Xin Selected Research

Gout

10/2020Evaluation of febuxostat initiation during an acute gout attack: A prospective, randomized clinical trial.
1/2018Zurampic Protects Pancreatic β-Cells from High Uric Acid Induced-Damage by Inhibiting URAT1 and Inactivating the ROS/AMPK/ERK Pathways.
1/2017Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population.
5/2015Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Xin Research Topics

Disease

48Neoplasms (Cancer)
08/2022 - 12/2007
10Inflammation (Inflammations)
10/2022 - 02/2013
8Neoplasm Metastasis (Metastasis)
04/2022 - 08/2008
7Hypoxia (Hypoxemia)
05/2022 - 06/2010
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2018
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2021 - 11/2017
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2015 - 11/2007
5Cardiomyopathies (Cardiomyopathy)
01/2021 - 08/2008
5Fibrosis (Cirrhosis)
01/2020 - 04/2013
4Carcinogenesis
08/2022 - 12/2011
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2014
4Squamous Cell Carcinoma of Head and Neck
11/2021 - 01/2019
4Gout
10/2020 - 05/2015
4Body Weight (Weight, Body)
01/2020 - 10/2011
4Cardiomegaly (Heart Hypertrophy)
10/2018 - 08/2008
4Hypertension (High Blood Pressure)
01/2018 - 12/2008
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 04/2007
3Papillary Thyroid Cancer
01/2022 - 01/2017
3Ischemia
01/2021 - 06/2010
3Wounds and Injuries (Trauma)
10/2019 - 08/2010
3Osteosarcoma (Osteogenic Sarcoma)
08/2018 - 01/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2018 - 08/2010
3Diabetic Cardiomyopathies
01/2018 - 02/2013
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2015 - 03/2010
2Lung Neoplasms (Lung Cancer)
05/2022 - 08/2014
2Macular Degeneration (Age-Related Maculopathy)
04/2022 - 01/2020
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2022 - 04/2014
2Thyroid Neoplasms (Thyroid Cancer)
04/2022 - 12/2021
2Thrombosis (Thrombus)
01/2022 - 09/2020
2Melanoma (Melanoma, Malignant)
07/2021 - 06/2019
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2021 - 08/2014
2Atherosclerosis
03/2021 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 12/2018
2Insulin Resistance
01/2021 - 03/2011
2Obesity
01/2021 - 05/2018
2Reperfusion Injury
01/2021 - 10/2016
2Circulating Neoplastic Cells
10/2020 - 01/2019
2Hyperuricemia
09/2020 - 01/2018
2Neuroblastoma
05/2020 - 09/2007
2Stomatitis
01/2020 - 10/2019
2Malnutrition (Nutritional Deficiencies)
01/2020 - 12/2010
2Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 12/2010
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 02/2013
2Brain Ischemia (Cerebral Ischemia)
11/2018 - 10/2016
2Hemorrhage
11/2017 - 06/2012
2Hyperglycemia
01/2016 - 03/2015

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2010
6Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2017
6Uric Acid (Urate)IBA
10/2020 - 05/2015
5DNA (Deoxyribonucleic Acid)IBA
05/2022 - 02/2013
5Histones (Histone)IBA
01/2022 - 01/2015
5Pharmaceutical PreparationsIBA
01/2022 - 01/2018
5sulforaphaneIBA
01/2021 - 04/2013
5Streptozocin (Streptozotocin)FDA Link
01/2018 - 09/2012
4Angiotensin IIIBA
10/2022 - 01/2017
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 11/2009
4Messenger RNA (mRNA)IBA
01/2022 - 08/2008
4Therapeutic UsesIBA
03/2015 - 03/2010
3MicroRNAs (MicroRNA)IBA
01/2022 - 07/2018
3Immune Checkpoint InhibitorsIBA
12/2021 - 01/2021
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2007
3CytokinesIBA
01/2020 - 06/2010
3ginsenoside Rg3IBA
06/2019 - 04/2007
3Phosphotransferases (Kinase)IBA
02/2019 - 08/2008
3MetallothioneinIBA
10/2018 - 03/2015
3Oxygen (Dioxygen)IBA
10/2015 - 06/2010
2AntioxidantsIBA
05/2022 - 06/2018
2Small Interfering RNA (siRNA)IBA
04/2022 - 08/2008
2IntegrinsIBA
04/2022 - 01/2021
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2022 - 06/2010
2InterferonsIBA
04/2022 - 11/2007
2Hormones (Hormone)IBA
01/2022 - 03/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 04/2013
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2020
2pembrolizumabIBA
12/2021 - 11/2021
2NitrogenIBA
11/2021 - 11/2012
2EverolimusFDA Link
07/2021 - 09/2011
2Actins (F Actin)IBA
03/2021 - 01/2019
2ProperdinIBA
03/2021 - 12/2018
2Complement Factor D (Factor D)IBA
03/2021 - 12/2018
2Complement C3 (C3 Complement)IBA
03/2021 - 12/2018
2Complement System Proteins (Complement)IBA
03/2021 - 12/2018
2Complement Factor H (Factor H)IBA
03/2021 - 12/2018
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2021 - 04/2010
2SuspensionsIBA
10/2020 - 01/2019
2Fluorouracil (Carac)FDA LinkGeneric
09/2020 - 09/2011
2CollagenIBA
01/2020 - 04/2013
2Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2018
2Disulfiram (Antabuse)FDA Link
01/2019 - 01/2019
2CateninsIBA
08/2018 - 02/2018
2Caspase 3 (Caspase-3)IBA
08/2018 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2018 - 05/2011
2Insulin (Novolin)FDA Link
01/2016 - 03/2011
2ZincIBA
03/2015 - 03/2014

Therapy/Procedure

21Radiotherapy
05/2022 - 09/2017
13Therapeutics
01/2022 - 12/2008
9Drug Therapy (Chemotherapy)
11/2021 - 08/2014
3Chemoradiotherapy
07/2021 - 01/2018
3Transplantation
01/2020 - 01/2016
2Immunotherapy
01/2021 - 01/2021